Time-restricted eating to entrain circadian rhythms, increase physiological responsiveness, and prevent stressor-induced frailty: A pilot randomized controlled trial.

J Geriatr OncolAug 8, 2026 (epub)

Amber S Kleckner, Carin L Clingan, Shalet James et al.

✦ AI-curated · Sources linked

In 30 seconds

This pilot randomized controlled trial assessed the feasibility of daytime-aligned time-restricted eating (TRE) and exploratory supportive-care outcomes in adults aged 55 years or older receiving treatment for prostate or metastatic breast cancer. Participants were assigned to a self-selected 10-hour eating window or control, with nutrition counseling for 12 weeks. Of 24 randomized participants, 20 completed the intervention (83.3% retention). The TRE group averaged a 9.2 ± 1.4-hour eating window versus 13.3 ± 1.5 hours in controls. There were no between-group effects on fatigue, frailty, or rhythm measures; greater rest-activity rhythm amplitude was associated with less fatigue.

Key findings

  • Twenty of 24 randomized participants completed the intervention, for 83.3% retention.
  • Across weeks 1–12, average eating windows were 9.2 ± 1.4 hours with TRE and 13.3 ± 1.5 hours in controls (p < 0.001).
  • No between-group effects were found for fatigue, frailty, or rhythm measures (p > 0.05).
  • Greater relative amplitude of rest-activity rhythms was associated with less fatigue (b ± SE = -6.3 ± 2.8, p = 0.03).

Why it matters

Fatigue and frailty can complicate cancer treatment in older adults. This pilot suggests that a dietitian-supported eating-window program can be implemented in this population, while its exploratory associations between circadian rhythm measures and supportive-care outcomes provide a rationale for further study. The absence of between-group effects means the findings do not establish that TRE improves fatigue or frailty.

What to keep in mind

This was a small pilot study, and only 20 participants completed the intervention. The study found no between-group effects on its fatigue, frailty, or rhythm measures.

Source

Published in J Geriatr Oncol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.